Mergers & Acquisitions Surge in Biotech: Factors Behind the 2025 Boom and Future Outlook
As the biotech and pharmaceutical sectors experience a remarkable surge in mergers and acquisitions (M&A) activity in early 2025, industry stakeholders are keenly observing the trends and drivers behind this transformative period. The promising outlook presents exciting opportunities, but it also raises critical questions about the long-term sustainability of such dynamic M&A activity. In this […]
Pharmaceutical News Roundup: Kennedy’s New Role at HHS, Major Deals & M&A Insights
The pharmaceutical landscape is constantly evolving, with key leadership changes and strategic business decisions shaping the future of the industry. This week, Robert F. Kennedy Jr. has officially accepted a pivotal position within the Department of Health and Human Services (HHS), a move that could have significant ramifications across healthcare policies and pharmaceutical regulation. In […]